Uncomplicated oocyte donation pregnancies are associated with a higher incidence of human leukocyte antigen alloantibodies

Hum Immunol. 2014 Jun;75(6):555-60. doi: 10.1016/j.humimm.2014.02.016. Epub 2014 Feb 12.

Abstract

Background: Fetuses in pregnancies conceived after oocyte donation (OD) have a higher degree of antigeneic dissimilarity with the mother compared to semi-allogeneic fetuses after natural conception. We questioned whether this leads to higher level of HLA antibody formation in OD pregnancies.

Method: Uncomplicated pregnancies after OD were compared with pregnancies conceived either spontaneously or by IVF. We calculated the number of HLA- and epitope mismatches. Maternal sera were screened for HLA antibodies with ELISA; child HLA specific antibody production was determined using CDC and Luminex with single antigen beads for class I and II.

Results: A significantly (p<0.0001) higher incidence of HLA antibody production was observed in women conceiving after OD (69%) compared to non-donor pregnancies (24-25%). The antibody formation was positively correlated with the number of fetomaternal antigen (Spearman's rho 0.95, p<0.0001) and epitope mismatches (Spearman's rho 0.91, p<0.0001). The number of HLA-DR mismatches between women and child was an independent risk factor for the production of HLA class I specific alloantibodies.

Conclusion: Women conceiving after OD have a higher risk of developing child-specific HLA antibodies; the higher the number of immunogenetic differences, the higher the chance these antibodies are formed. The high incidence of antibody production also strongly depends upon the number of HLA-DR mismatches. Despite the stronger antibody response, OD was associated with uncomplicated pregnancy in cases included in this study.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Epitopes / blood
  • Epitopes / immunology
  • Female
  • Fertilization in Vitro
  • Gene Expression
  • HLA-DR Antigens / genetics
  • HLA-DR Antigens / immunology*
  • Humans
  • Isoantibodies / biosynthesis
  • Isoantibodies / blood*
  • Middle Aged
  • Oocyte Donation*
  • Pregnancy
  • Risk Factors
  • Treatment Outcome

Substances

  • Epitopes
  • HLA-DR Antigens
  • Isoantibodies